🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
562,02 USD
Máx. histórico
608,49
2 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,64%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-0,65%
Cierre anterior
565,72
Rango de hoy
559,41 – 569,45
Volumen hoy
454.934
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,22 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 2 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/08/2010 | 49,90 | 50,15 | 49,47 | 49,65 | -0,70% | 1,36% | 290.300 |
| 17/08/2010 | 50,09 | 50,49 | 49,72 | 50,00 | +0,50% | 1,54% | 177.800 |
| 16/08/2010 | 49,54 | 50,01 | 49,22 | 49,75 | -0,24% | 1,59% | 295.700 |
| 13/08/2010 | 50,39 | 50,56 | 49,66 | 49,87 | -1,27% | 1,79% | 398.400 |
| 12/08/2010 | 49,82 | 51,08 | 49,54 | 50,51 | +0,30% | 3,09% | 220.800 |
| 11/08/2010 | 50,85 | 51,34 | 49,85 | 50,36 | -2,55% | 2,93% | 415.200 |
| 10/08/2010 | 51,77 | 52,00 | 51,43 | 51,68 | -0,86% | 1,10% | 235.600 |
| 09/08/2010 | 51,85 | 52,28 | 51,72 | 52,13 | +0,71% | 1,08% | 177.200 |
| 06/08/2010 | 50,22 | 51,85 | 50,00 | 51,76 | +1,73% | 3,68% | 605.400 |
| 05/08/2010 | 50,14 | 50,92 | 49,94 | 50,88 | +0,75% | 1,95% | 655.400 |
| 04/08/2010 | 50,06 | 50,81 | 49,00 | 50,50 | +1,28% | 3,62% | 386.600 |
| 03/08/2010 | 49,88 | 50,31 | 49,53 | 49,86 | -0,46% | 1,56% | 498.500 |
| 02/08/2010 | 49,50 | 50,15 | 49,26 | 50,09 | +2,45% | 1,80% | 576.600 |
| 30/07/2010 | 47,22 | 49,36 | 46,63 | 48,89 | +3,54% | 5,78% | 559.000 |
| 29/07/2010 | 47,33 | 47,81 | 46,56 | 47,22 | +0,58% | 2,64% | 1.116.600 |
| 28/07/2010 | 47,22 | 50,50 | 46,90 | 46,95 | -8,76% | 7,62% | 2.383.200 |
| 27/07/2010 | 50,65 | 52,33 | 50,53 | 51,46 | +1,88% | 3,55% | 923.000 |
| 26/07/2010 | 50,30 | 51,58 | 50,21 | 50,51 | +0,94% | 2,72% | 471.800 |
| 23/07/2010 | 48,59 | 50,26 | 48,44 | 50,04 | +2,58% | 3,75% | 660.600 |
| 22/07/2010 | 48,84 | 49,40 | 48,47 | 48,78 | +0,72% | 1,90% | 349.500 |
| 21/07/2010 | 48,95 | 49,11 | 48,32 | 48,43 | -0,66% | 1,61% | 446.700 |
| 20/07/2010 | 47,97 | 48,84 | 47,46 | 48,75 | +0,81% | 2,88% | 479.400 |
| 19/07/2010 | 48,27 | 48,63 | 47,89 | 48,36 | +0,65% | 1,53% | 179.300 |
| 16/07/2010 | 49,56 | 49,80 | 47,66 | 48,05 | -3,49% | 4,32% | 686.200 |
| 15/07/2010 | 49,73 | 49,98 | 49,30 | 49,79 | -0,06% | 1,37% | 470.400 |
| 14/07/2010 | 49,96 | 50,13 | 49,47 | 49,82 | -0,42% | 1,32% | 490.800 |
| 13/07/2010 | 49,36 | 50,53 | 49,36 | 50,03 | +2,00% | 2,37% | 286.700 |
| 12/07/2010 | 50,00 | 50,84 | 48,63 | 49,05 | -2,47% | 4,42% | 401.300 |
| 09/07/2010 | 49,05 | 50,37 | 48,95 | 50,29 | +2,15% | 2,90% | 345.000 |
| 08/07/2010 | 48,09 | 49,36 | 48,03 | 49,23 | +3,01% | 2,77% | 591.200 |